Roche

F. Hoffmann-La Roche AG, or Roche, is a Swiss global healthcare corporation that engages in various healthcare sectors, including pharmaceuticals, diagnostics, and biotechnology. The company's headquarters are in Basel. Roche has a substantial presence in biotech and is actively involved in biotechnology product research and development.

Roche creates and sells a wide range of medications and diagnostic items used in illness diagnosis, prevention, and treatment. The cancer medications Avastin, Herceptin, and Rituxan are among its most well-known products, as well as diagnostic tests for disorders such as HIV, hepatitis, and cancer.

Roche Pharma Research and Early Development (pRED) is a biotechnology division that focuses on the discovery and development of novel medications and cures utilizing biotechnology. The research efforts of pRED involve using genomics, proteomics, and other advanced technologies to identify novel drug targets and create new treatments for various diseases, including cancer, autoimmune disorders, and infectious diseases.

Roche is well-known for its dedication to innovation and heavy investment in research and development. Every year, the corporation invests billions of dollars in R&D, and its efforts have resulted in significant advancements in the field of healthcare.

Roche has a global workforce of over 100,000 individuals and works in more than 100 countries. The company has a significant presence in both developed and emerging areas and is dedicated to bringing its products and services to people all around the world.

Founded: 1896

Headquarters: Basel, Switzerland

Website: https://www.roche.com/